Colon Cancer - UPDATE 1-Bristol-Myers to refile for Erbitux in lung cancer - Reuters
UPDATE 1-Bristol-Myers to refile for Erbitux in lung cancer - Reuters
LOS ANGELES, Jan 23 (Reuters) - Bristol-Myers Squibb Co ( BMY.N ), which last year acquired ImClone Systems, said on Friday the companies have decided to withdraw, and eventually resubmit, an application with U.S. regulators to market cancer drug
CORRECTED-Bristol-Myers to refile for Erbitux for lung cancer - FXStreet.com
LOS ANGELES, Jan 23 (Reuters) - Bristol-Myers Squibb Co and ImClone Systems, which last year was acquired by Eli Lilly and Co, said on Friday they will withdraw, and eventually resubmit, an application with U.S. regulators to market cancer drug
Burns not letting cancer slow him down - NBC Sports
TAMPA, Fla. (AP) -Pat Burns was scouting a hockey game Tuesday night, which means it was another good day for the former NHL coach. The 56-year old Burns recently confirmed he has lung cancer and knows the long-term outlook is “not good'’ in his
Ballast Point finances cancer testing firm - Tampa Bay Business Journal
Ballast Point Ventures invested $3 million in MolecularMD Corp. , a molecular diagnostic company. The funding will be used to build MolecularMD s corporate infrastructure and to expand the company s assay portfolio, Ballast Point said in a